Vertex Pharmaceuticals
VRTX
VRTX
1,217 hedge funds and large institutions have $68B invested in Vertex Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 186 funds opening new positions, 432 increasing their positions, 438 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,217
Holders Change
+98
Holders Change %
+8.76%
% of All Funds
19.64%
Holding in Top 10
27
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-30.77%
% of All Funds
0.44%
New
186
Increased
432
Reduced
438
Closed
64
Calls
$420M
Puts
$390M
Net Calls
+$29.4M
Net Calls Change
+$20.6M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$745M |
| 2 |
JPMorgan Chase & Co
New York
|
$1.59B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$5.16B |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$184M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$6.22B |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSPAM
1276
Cary Street Partners Asset Management
Richmond,
Virginia
| – | -$11K | -37 | Closed |
|
1277
Optiver Holding
Amsterdam,
Netherlands
| – | -$9K | -32 | Closed |
|
|
EC
1278
EdgeRock Capital
Denver,
Colorado
| – | -$5K | -16 | Closed |
|
|
HPC
1279
HM Payson & Co
Portland,
Maine
| – | -$3K | -12 | Closed |
|
|
OCM
1280
Osterweis Capital Management
San Francisco,
California
| – | -$2K | -6 | Closed |
|